Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.

Zeeb, Marius; Tepekule, Burcu; Kusejko, Katharina; Reiber, Claudine; Kälin, Marisa; Bartl, Lena; Notter, Julia; Furrer, Hansjakob; Hoffmann, Matthias; Hirsch, Hans H; Calmy, Alexandra; Cavassini, Matthias; Labhardt, Niklaus D; Bernasconi, Enos; Braun, Dominique L; Günthard, Huldrych F; Kouyos, Roger D; Nemeth, Johannes (2023). Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland. Clinical infectious diseases, 77(9), pp. 1303-1311. Oxford University Press 10.1093/cid/ciad330

[img]
Preview
Text
ciad330.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (941kB) | Preview

BACKGROUND

People with human immunodeficiency virus type 1 (HIV) (PWH) are frequently coinfected with Mycobacterium tuberculosis (MTB) and at risk for progressing from asymptomatic latent TB infection (LTBI) to active tuberculosis (TB). LTBI testing and preventive treatment (TB specific prevention) are recommended, but its efficacy in low transmission settings is unclear.

METHODS

We included PWH enrolled from 1988 to 2022 in the Swiss HIV Cohort study (SHCS). The outcome, incident TB, was defined as TB ≥6 months after SHCS inclusion. We assessed its risk factors using a time-updated hazard regression, modeled the potential impact of modifiable factors on TB incidence, performed mediation analysis to assess underlying causes of time trends, and evaluated preventive measures.

RESULTS

In 21,528 PWH, LTBI prevalence declined from 15.1% in 2001 to 4.6% in 2021. Incident TB declined from 90.8 cases/1000 person-years in 1989 to 0.1 in 2021. A positive LTBI test showed a higher risk for incident TB (HR 9.8, 5.8-16.5) but only 10.5% of PWH with incident TB were tested positive. Preventive treatment reduced the risk in LTBI test positive PWH for active TB (relative risk reduction, 28.1%, absolute risk reduction 0.9%). On population level, the increase of CD4 T-cells and reduction of HIV viral load were the main driver of TB decrease.

CONCLUSIONS

TB specific prevention is effective in selected patient groups. On a population level, control of HIV-1 remains the most important factor for incident TB reduction. Accurate identification of PWH at highest risk for TB is an unmet clinical need.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Furrer, Hansjakob

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1537-6591

Publisher:

Oxford University Press

Language:

English

Submitter:

Pubmed Import

Date Deposited:

01 Jun 2023 10:22

Last Modified:

01 Jun 2024 00:25

Publisher DOI:

10.1093/cid/ciad330

PubMed ID:

37257071

BORIS DOI:

10.48350/183095

URI:

https://boris.unibe.ch/id/eprint/183095

Actions (login required)

Edit item Edit item
Provide Feedback